Navigation Links
MAQUET Cardiovascular Responds to Terumo Complaint About VASOVIEW Endoscopic Vessel Harvesting Systems
Date:9/2/2008

SAN JOSE, Calif., Sept. 2 /PRNewswire/ -- MAQUET Cardiovascular LLC announced today that it was served with a complaint filed by Terumo Cardiovascular Systems Corp. (Terumo CSC) in the United States District Court for the Northern District of California. The complaint alleges that MAQUET's VASOVIEW Endoscopic Vessel Harvesting Systems infringe a certain U.S. patent.

In April 2008, MAQUET filed patent infringement complaints against Terumo CSC and Terumo Corporation with the International Trade Commission (ITC) and in the United States District Court for the Northern District of California, alleging that Terumo's VirtuoSaph(TM) endoscopic vessel harvesting system infringes two MAQUET U.S. patents. The ITC case seeks to exclude the infringing products from importation into the United States and the district court case seeks monetary damages and an injunction. The complaint filed by Terumo will not affect the actions filed by MAQUET.

MAQUET will continue to protect and enforce its intellectual property rights, and will aggressively defend the law suit filed by Terumo.

About MAQUET Cardiovascular

MAQUET Cardiovascular LLC is a division within the Medical Systems business, part of the publicly listed Swedish group of companies GETINGE AB. MAQUET Cardiovascular was formed by combining MAQUET Cardiopulmonary with Boston Scientific's Vascular Surgery and Cardiac Surgery divisions, which included the products and services of Guidant Cardiac Surgery. The creation of this new organization enables MAQUET to offer a comprehensive array of patient care solutions for less-invasive endoscopic vessel harvesting, off- and on- pump coronary artery bypass surgery, and vascular grafts.

MAQUET has 170 years of healthcare experience, and is committed to becoming "The Gold Standard" for therapeutic medical equipment across the globe. As a market leader, MAQUET offers innovative medical solutions from three divisions: Surgical Workplaces, Critical Care, and Cardiovascular.

MAQUET Medical Systems is headquartered in Rastatt, Germany and employs 4,100 employees, has more than 30 international sales and service subsidiaries, and a network of over 200 dealer distributors worldwide. For more information, please visit http://www.maquet.com and http://www.getinge.com.

MAQUET Cardiovascular LLC

170 Baytech Drive

San Jose, CA 95134

Press Contact:

Nils Rosen

Vice President, Marketing

Phone: (408) 635-7200

nils.rosen@maquet.com


'/>"/>
SOURCE MAQUET Cardiovascular LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
2. MAQUET Cardiovascular Launches HEARTSTRING III Proximal Seal System for Coronary Artery Bypass Graft Surgery
3. MAQUET Cardiovascular Announces Patent Infringement Complaints Against Terumo
4. ARJO / Getinge / Maquet Announces New West Coast Showroom Opening
5. Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke
6. Journal of Cardiovascular Electrophysiology Publishes Data Showing Ranolazine Shortened QT Interval and Improved Cardiac Relaxation in Study of Patients With Long QT Syndrome
7. New discovery may lead to immunization against cardiovascular disease
8. Geneva Offers First Cardiovascular Technology Graduate Program in the Nation
9. Leading worldwide cause of cardiovascular disease may be modified by diet
10. Building a Fully Integrated Cardiovascular Imaging and Information System Webinar
11. Omega-3, Some Omega-6 Fatty Acids Boost Cardiovascular Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... Like most hospitals across the ... in large part by the Hospital Readmission Reduction Program (HRRP), the return of a ... area for hospitals across the nation. While many providers are struggling to leverage limited ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Mason Pasquin Agency, ... and business owners in and around the Hampton Roads metropolitan region, is joining ... forms of domestic violence. , There are multiple categories of domestic violence – ...
(Date:2/16/2017)... ... February 17, 2017 , ... ... over 10 years of research, development and clinical trials, the founder of Chigurupati ... a patented compound of FDA approved ingredients that when infused into alcohol, protect ...
(Date:2/16/2017)... ... February 17, 2017 , ... Teaching nursing care of vulnerable children is ... ACE.P (pediatrics) is being created with the support of the Hearst Foundations. An initiative ... ACE.P will address what has been identified as a critical gap in preparing the ...
(Date:2/16/2017)... ... February 16, 2017 , ... As a reflection ... patient care, NWH has achieved Magnet® recognition for the second time, ... 2017. The American Nurses Credentialing Center’s Magnet Recognition Program® distinguishes organizations that meet ...
Breaking Medicine News(10 mins):
(Date:2/19/2017)... ORLANDO, Fla. , Feb. 18, 2017 ... that positive Phase 1 clinical data for Nektar,s lead ... (RCC) were presented at ASCO GU 2017.  NKTR-214 is ... T cells and Natural Killer (NK) cell abundance directly ... on these immune cells.  The results were presented by ...
(Date:2/17/2017)... 17, 2017 Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, ... global ablation technologies market is expected to grow at a CAGR ... market is expected to grow at a CAGR of 9.5% from ... and $9.05bn in 2026. ... How this report will benefit you Read on to ...
(Date:2/17/2017)... Feb. 17, 2017 Theravance Biopharma, Inc. ... the "Company") today announced the presentation of positive ... orally administered pan-Janus kinase (JAK) inhibitor designed to ... Congress of the European Crohn,s and Colitis Organization ... further data from its completed Phase 1 study ...
Breaking Medicine Technology: